Imagen de Portada

Intestinal Ultrasound Transmural Healing Was Associated With Improved Long‐Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Clara Yzet, Amélie Plancke, Franck Brazier, Lucien Grados, Elise Derval, Louise Ghilardi, Momar Diouf, Adrien Ollier, Mathurin Fumery
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
por: Nicolas Richard, et al.
Publicado: (2025)

Editorial: “Striding” Towards Transmural Healing: Redefining Deep Remission as a Treatment Target in Crohn's Disease
por: Rohita Reji, et al.
Publicado: (2026)

Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease
por: Moeko Komatsu, et al.
Publicado: (2024)

Letter: Intestinal Ultrasound‐Prioritising Progress
por: Kacie H. Denton, et al.
Publicado: (2026)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows?
por: J. M. B. W. Vos, et al.
Publicado: (2025)

Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
por: Sara Massironi, et al.
Publicado: (2025)

Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion
por: Cathy Lu, et al.
Publicado: (2025)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply
por: Ryan M. Mathias, et al.
Publicado: (2025)

Editorial for ‘Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance, and Expansion’
por: Cameron Kendall, et al.
Publicado: (2025)

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
por: Nicolas Richard, et al.
Publicado: (2026)

Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
por: Shlomi Cohen, et al.
Publicado: (2025)

Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation
por: Vlasios Gourgiotis, et al.
Publicado: (2025)

The Association of Faecal Calprotectin Measurements With Endo‐Histological Remission in Ulcerative Colitis: A Pooled Analysis
por: Laurie‐Rose Dubé, et al.
Publicado: (2026)

Editorial: Remission Ambition—How Far Should We Push in Older Adults? Authors' Reply
por: Catherine Z. Tang, et al.
Publicado: (2025)

Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
por: Mohammad Shehab, et al.
Publicado: (2025)

The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease
por: Sebastiaan ten Bokkel Huinink, et al.
Publicado: (2025)

Meta‐analysis: Intestinal ultrasound to evaluate colonic contents and constipation
por: R. M. Mathias, et al.
Publicado: (2024)

Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU
por: María José Casanova, et al.
Publicado: (2025)

Letter: The Simple Endoscopic Score for Predicting Crohn's Disease Progression—Not as Simple as It Sounds
por: Ziheng Calvin Xu, et al.
Publicado: (2025)

Letter: Optimising Targeted Next‐Generation Sequencing for Intestinal Tuberculosis Diagnosis—Methodological Considerations
por: Haleema Rahman
Publicado: (2025)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis
por: Saverio Pochesci, et al.
Publicado: (2026)

Editorial: Endoscopic Activity is an Essential Tool for Patients' Management, Even in Mild Crohn's Disease
por: Marco Mendolaro, et al.
Publicado: (2025)

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
por: Mathilde Osty, et al.
Publicado: (2025)

Review: Human Intestinal Barrier—Optimal Measurement and Effects of Diet in the Absence of Overt Inflammation or Ulceration
por: Michael Camilleri
Publicado: (2025)

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study
por: Mitchell Shiffman, et al.
Publicado: (2024)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet? Author's Reply
por: Aurelien Amiot, et al.
Publicado: (2025)

Editorial: Another brick in the CDST wall
por: Aurelien Amiot, et al.
Publicado: (2024)

Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
por: Lingna Ye, et al.
Publicado: (2025)

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply
por: Arta Aliu, et al.
Publicado: (2024)

Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease
por: Catherine Z. Tang, et al.
Publicado: (2025)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis. Authors' Reply
por: Pierfrancesco Visaggi, et al.
Publicado: (2026)

Letter: Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
por: Maryam Irshad, et al.
Publicado: (2025)

Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis
por: Ikuo Hirano, et al.
Publicado: (2025)

A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
por: Maral Amangurbanova, et al.
Publicado: (2024)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?
por: Louise J. M. Alferink, et al.
Publicado: (2024)

Letter: A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
por: Xiaojuan Liu, et al.
Publicado: (2025)

Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study
por: Maria Mironova, et al.
Publicado: (2024)

Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi‐Centre Study
por: Pierfrancesco Visaggi, et al.
Publicado: (2026)

Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study
por: Ahmed Helmy
Publicado: (2025)

Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study: Authors' Reply
por: Gamal Shiha, et al.
Publicado: (2025)